. 2022 Aug 15;9:856216. doi: 10.3389/fnut.2022.856216

TABLE 5.

Between-group analysis of clinical features.

Outcomes	Between-group analysis		Between-group post-intervention–baseline difference analysis p-value

	Baseline p-value	Post-intervention p-value
FIQR (Range: 0−100)	0.676^a	0.004^a	0.001^b
VAS (Range: 0−10)	0.937^a	0.001^a	0.002^b
VAS GI (Range: 0−10)	0.660^a	0.023^a	0.002^b
BPI (Range: 0−20)	0.015^a	0.001^a	0.011^b
PSQI (Range: 0−21)	0.808^a	0.073^a	0.048^b
FSS (Range: 0−7)	0.003^a	0.001^a	0.042^a
SF36 (Range: 0−100)	0.047^a	0.001^a	0.045^a
SF36 Physical Component (Range: 0−100)	0.454^a	0.002^a	0.008^b
SF36 Mental Component (Range: 0−100)	0.015^a	0.016^a	0.947^b

FIQR, Revised Fibromyalgia Impact Questionnaire; VAS, Visual Analog Pain Scale; VAS GI, Visual Analog Scale from gastrointestinal symptoms; BPI, Brief Pain Inventory; PSQI, Pittsburg Sleep Quality Index; FSS, Fatigue Severity Survey; SF36, Short Form 36.

^ap-value calculated by Mann−Whitney between control and intervention groups mean values;

^bp-value calculated by t-test for independent samples, between control and intervention mean values.